Get the Stockscreener App
2.17
2.25%
-0.05
Immix Biopharma Inc Stock (IMMX) Forecast
The Immix Biopharma Inc (IMMX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.3577, representing a -83.52% decrease from the current price of $2.17. The highest analyst price target is $0.4092, and the lowest is $0.3061.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMMX Price Target
Average 0.7749
(-64.29% Downside)
Is Immix Biopharma Inc (IMMX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.37 | Neutral |
| STOCH(9,6) | 29.04 | Neutral |
| STOCHRSI(14) | 21.40 | Neutral |
| MACD(12,26) | 0.0993 | Sell |
| ADX(14) | 21.00 | Neutral |
| William %R | -65.06 | Neutral |
| CCI(14) | -16.67 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.195
Sell
|
2.1706
Sell
|
| MA20 |
2.1405
Buy
|
2.108
Buy
|
| MA50 |
1.8372
Buy
|
1.9536
Buy
|
| MA100 |
1.8549
Buy
|
1.9589
Buy
|
| MA200 |
2.1098
Buy
|
2.2876
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, IMMX could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on IMMX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.37 indicates that IMMX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.04 indicates that IMMX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 21.4 indicates that IMMX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -16.67 indicates that IMMX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IMMX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immix Biopharma Inc financial reports and earnings history, Immix Biopharma Inc (IMMX) stock could reach $7.1838 by 2030, $2.5477 by 2040 and $18.75 by 2050. See the projected annual prices until 2050 of the Immix Biopharma Inc stock below:
- Immix Biopharma Inc (IMMX) is expected to reach an average price of $10.51 in 2035, with a high prediction of $7.95 and a low estimate of $3.1265. This indicates an $384.33% rise from the last recorded price of $2.17.
- Immix Biopharma Inc (IMMX) stock is projected to chart a bullish course in 2040, with an average price target of $3.5321, representing an $62.77% surge from its current level. The forecast ranges from a conservative $2.9434 to a sky-high $2.5477.
- Our analysts predict Immix Biopharma Inc (IMMX) to jump 445.13% by 2045, soaring from $12.16 to an average price of $11.83, potentially reaching $12.69. While $12.16 is the low estimate, the potential upside is significant.
- Immix Biopharma Inc (IMMX) stock is expected to climb by 2050, reaching an average of $18.93, a $772.25% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.75 and $18.85, respectively, highlighting the market's uncertainty.
Immix Biopharma Inc Stock (IMMX) Year by Year Forecast
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2025
Immix Biopharma Inc Stock (IMMX) is expected to reach an average price of $0.7749 in 2025, with a high prediction of $1.5445 and a low estimate of $0.00532. This indicates an -64.29% fall from the last recorded price of $2.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.5992 | $0.3061 | $0.4092 | -72.39% |
| February, 2025 | $0.7755 | $0.8357 | $0.7755 | -64.26% |
| March, 2025 | $1.3417 | $1.152 | $1.1777 | -38.17% |
| April, 2025 | $1.6095 | $1.4382 | $1.5445 | -25.83% |
| May, 2025 | $1.2815 | $1.2059 | $1.2307 | -40.94% |
| June, 2025 | $0.0869 | $0.4269 | $0.9673 | -95.99% |
| July, 2025 | $0.2903 | $0.0403 | $0.4802 | -86.62% |
| August, 2025 | $0.106 | $0.0329 | $1.0071 | -95.12% |
| September, 2025 | $0.3822 | $0.1991 | $0.0843 | -82.39% |
| October, 2025 | $0.265 | $0.4188 | $0.2984 | -87.79% |
| November, 2025 | $0.4412 | $0.00532 | $0.8819 | -79.67% |
| December, 2025 | $0.206 | $0.0609 | $0.396 | -90.51% |
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2026
The predicted value for Immix Biopharma Inc (IMMX) in 2026 is set at an average of $3.0981. Estimates vary from a peak of $6.1527 to a trough of $0.0435, indicating an +42.77% surge from the present price of $2.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.3297 | $0.1663 | $1.0063 | -84.80% |
| February, 2026 | $0.1135 | $0.0435 | $0.7632 | -94.77% |
| March, 2026 | $0.1773 | $0.0473 | $0.2773 | -91.83% |
| April, 2026 | $1.6345 | $0.1707 | $2.0145 | -24.68% |
| May, 2026 | $1.6582 | $1.0248 | $3.0479 | -23.58% |
| June, 2026 | $2.682 | $1.2917 | $3.072 | +23.60% |
| July, 2026 | $5.6592 | $2.3556 | $5.8592 | +160.79% |
| August, 2026 | $4.253 | $4.163 | $6.1527 | +95.99% |
| September, 2026 | $1.7502 | $0.9102 | $4.3164 | -19.35% |
| October, 2026 | $2.064 | $1.2336 | $2.3495 | -4.89% |
| November, 2026 | $1.6877 | $1.1343 | $2.3174 | -22.22% |
| December, 2026 | $0.8549 | $0.6115 | $1.7612 | -60.60% |
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immix Biopharma Inc (IMMX) is $2.5238, with a high forecast of $4.2692 and a low forecast of $0.7784. This indicates an +16.30% increase from the last price of $2.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.7762 | $0.7784 | $1.56 | -18.15% |
| February, 2027 | $1.9587 | $2.0387 | $2.1526 | -9.74% |
| March, 2027 | $4.1843 | $2.6018 | $3.8643 | +92.82% |
| April, 2027 | $3.4568 | $3.6068 | $3.5348 | +59.30% |
| May, 2027 | $4.4492 | $4.1599 | $4.2692 | +105.03% |
| June, 2027 | $3.5548 | $3.5848 | $4.1923 | +63.82% |
| July, 2027 | $3.4573 | $3.3942 | $2.908 | +59.32% |
| August, 2027 | $2.7497 | $2.8997 | $2.9604 | +26.72% |
| September, 2027 | $3.3353 | $2.9922 | $2.9003 | +53.70% |
| October, 2027 | $3.4378 | $3.4184 | $3.2678 | +58.42% |
| November, 2027 | $3.8303 | $3.6109 | $3.6603 | +76.51% |
| December, 2027 | $4.0858 | $3.9765 | $3.9158 | +88.29% |
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2028
In 2028, Immix Biopharma Inc (IMMX) is projected to reach an average price of $2.5334, with a high projection of $4.029 and a low estimate of $1.0379. This indicates an +16.75% rise from the last price of $2.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.6783 | $3.6635 | $4.029 | +69.51% |
| February, 2028 | $2.6108 | $3.0508 | $3.6614 | +20.31% |
| March, 2028 | $2.2464 | $2.5963 | $2.4732 | +3.52% |
| April, 2028 | $2.2488 | $2.1725 | $1.8538 | +3.63% |
| May, 2028 | $2.5844 | $2.4282 | $2.2551 | +19.10% |
| June, 2028 | $2.4952 | $2.6075 | $2.4469 | +14.99% |
| July, 2028 | $2.0594 | $2.0562 | $2.31 | -5.10% |
| August, 2028 | $2.0549 | $2.1018 | $2.2056 | -5.30% |
| September, 2028 | $1.7074 | $1.6243 | $1.6181 | -21.32% |
| October, 2028 | $1.7799 | $1.7205 | $1.7499 | -17.98% |
| November, 2028 | $1.6755 | $1.8055 | $1.8392 | -22.79% |
| December, 2028 | $0.1679 | $1.0379 | $1.2386 | -92.26% |
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2029
The 2029 price forecast for Immix Biopharma Inc Stock (IMMX) is $3.4446 on average, with a high prediction of $6.8864 and a low estimate of $0.00286. This represents an +58.74% increase from the previous price of $2.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0735 | $0.1342 | $1.2758 | -96.61% |
| February, 2029 | $1.004 | $0.00286 | $1.394 | -53.73% |
| March, 2029 | $1.5516 | $0.691 | $2.1678 | -28.50% |
| April, 2029 | $3.0991 | $0.8684 | $4.5553 | +42.82% |
| May, 2029 | $0.7635 | $0.3666 | $3.756 | -64.82% |
| June, 2029 | $0.451 | $0.041 | $0.905 | -79.21% |
| July, 2029 | $0.4986 | $0.2483 | $0.8948 | -77.02% |
| August, 2029 | $0.527 | $0.0377 | $0.5883 | -75.71% |
| September, 2029 | $3.6297 | $0.5233 | $1.8698 | +67.27% |
| October, 2029 | $5.0481 | $4.9893 | $5.2688 | +132.63% |
| November, 2029 | $6.9968 | $5.6777 | $6.0668 | +222.43% |
| December, 2029 | $6.5355 | $6.8655 | $6.8864 | +201.17% |
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2030
Immix Biopharma Inc Stock (IMMX) is expected to reach an average price of $5.8263 in 2030, with a high forecast of $7.1838 and a low forecast of $4.4688. This signifies an +168.49% surge from the last price of $2.17.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.3638 | $6.5751 | $7.1838 | +239.35% |
| February, 2030 | $5.9025 | $6.6924 | $7.0935 | +172.01% |
| March, 2030 | $5.9912 | $6.2012 | $6.1022 | +176.09% |
| April, 2030 | $5.5799 | $5.8803 | $5.7406 | +157.14% |
| May, 2030 | $5.6083 | $5.6396 | $5.559 | +158.45% |
| June, 2030 | $5.957 | $6.008 | $5.8853 | +174.52% |
| July, 2030 | $6.3954 | $6.1867 | $6.2254 | +194.72% |
| August, 2030 | $6.5341 | $6.5147 | $6.3841 | +201.11% |
| September, 2030 | $6.0328 | $6.1211 | $6.5134 | +178.01% |
| October, 2030 | $5.0012 | $5.4412 | $6.0921 | +130.47% |
| November, 2030 | $4.8599 | $5.0402 | $4.8099 | +123.96% |
| December, 2030 | $4.1986 | $4.4688 | $4.4695 | +93.48% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):